Imdusiran IM-PROVE I, II & III clinical trials expense
Arbutus Biopharma Corporation·Business Segments·1 segment
Breakdown
Segments
Business SegmentsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Business Segments | $2.17M | $1.41M | $1.07M | $175K | $891K |
| Total | $2.17M | $1.41M | $1.07M | $175K | $891K |